Craig Thompson — Chief Medical Officer of Interventional Cardiology and Senior Vice President at Boston Scientific

Dr. Craig Thompson has been Chief Medical Officer of Interventional Cardiology and Senior Vice President at Boston Scientific Corporation since January 6, 2014. Dr. Thompson is global leader in complex cardiac interventions, serves a key role in driving the development of innovative medical solutions within the Boston Scientific Interventional Cardiology business. He has a wealth of clinical and academic experience, performed thousands of structural cardiac, coronary, and vascular catheter-based procedures. Dr. Thompson also served as an advisor for many cardiovascular device companies and he participated in the early development of technologies for the treatment of coronary total occlusions, including the BridgePoint coronary chronic total occlusion system acquired by Boston Scientific in 2012. Dr. Thompson is a very experienced interventional cardiologist who is an important addition to Boston Scientific Corporation's clinical team. Prior to Yale, Dr. Thompson served as director of Cardiovascular Catheterization and Intervention at Dartmouth Hitchcock Medical Center/Dartmouth Medical School. Dr. Thompson previously served as director, Invasive Cardiology and Vascular Medicine, Yale New Haven Hospital, and was associate professor of medicine, Yale University School of Medicine. He holds an undergraduate degree from the University of Southern Mississippi, medical degree from the University of Mississippi, and masters of medical science in clinical investigation from the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology. Dr. Thompson completed post-doctoral training in clinical cardiology at Brigham and Women's Hospital/Harvard Medical School and interventional cardiology and endovascular intervention at Massachusetts General Hospital/Harvard Medical School.